Literature DB >> 10354288

Essential arterial hypertension and stone disease.

L Borghi1, T Meschi, A Guerra, A Briganti, T Schianchi, F Allegri, A Novarini.   

Abstract

BACKGROUND: Cross-sectional studies have shown that nephrolithiasis is more frequently found in hypertensive patients than in normotensive subjects, but the pathogenic link between hypertension and stone disease is still not clear.
METHODS: Between 1984 and 1991, we studied the baseline stone risk profile, including supersaturation of lithogenic salts, in 132 patients with stable essential hypertension (diastolic blood pressure of more than 95 mm Hg) without stone disease and 135 normotensive subjects (diastolic blood pressure less than 85 mm Hg) without stone disease who were matched for age and sex (controls). Subsequently, both controls and hypertensives were followed up for at least five years to check on the eventual formation of kidney stones.
RESULTS: Baseline urine levels in hypertensive males were different from that of normotensive males with regards to calcium (263 vs. 199 mg/day), magnesium (100 vs. 85 mg/day), uric acid (707 vs. 586 mg/day), and oxalate (34.8 vs. 26.5 mg/day). Moreover, the urine of hypertensive males was more supersaturated for calcium oxalate (8.9 vs. 6.1) and calcium phosphate (1.39 vs. 0.74). Baseline urine levels in hypertensive females were different from that of normotensive females with regards to calcium (212 vs. 154 mg/day), phosphorus (696 vs. 614 mg/day), and oxalate (26.2 vs. 21.7 mg/day), and the urine of hypertensive females was more supersaturated for calcium oxalate (7.1 vs. 4.8). These urinary alterations were only partially dependent on the greater body mass index in hypertensive patients. During the follow-up, 19 out of 132 hypertensive patients and 4 out of 135 normotensive patients had stone episodes (14.3 vs. 2.9%, chi-square 11.07, P = 0.001; odds ratio 5.5, 95% CI, 1.82 to 16.66). Of the 19 stone-former hypertensive patients, 12 formed calcium calculi, 5 formed uric acid calculi, and 2 formed nondetermined calculi. Of the urinary factors for lithogenous risk, those with the greatest predictive value were supersaturation of calcium oxalate for calcium calculi and uric acid supersaturation for uric acid calculi.
CONCLUSIONS: A significant percentage of hypertensive subjects has a greater risk of renal stone formation, especially when hypertension is associated with excessive body weight. Higher oxaluria and calciuria as well as supersaturation of calcium oxalate and uric acid appear to be the most important factors. Excessive weight and consumption of salt and animal proteins may also play an important role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354288     DOI: 10.1046/j.1523-1755.1999.00483.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  53 in total

Review 1.  The DASH trials implicate dysfunction in calcium regulation in the pathogenesis of human hypertension.

Authors:  A G Logan
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  Risk of Nephrolithiasis in Patients With Sleep Apnea: A Population-Based Cohort Study.

Authors:  Sheng-Han Tsai; Marshall L Stoller; Benjamin A Sherer; Zi-Hao Chao; Tao-Hsin Tung
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

3.  Diabetes mellitus and kidney stone formation.

Authors:  Dean G Assimos
Journal:  Rev Urol       Date:  2006

4.  A decrease in blood pressure following pyelolithotomy but not extracorporeal lithotripsy.

Authors:  Davor Eterović; Marijan Situm; Ljubica Juretić-Kuscić; Zeljko Dujić
Journal:  Urol Res       Date:  2004-12-24

5.  Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Authors:  Wonngarm Kittanamongkolchai; Kristin C Mara; Ramila A Mehta; Lisa E Vaughan; Aleksandar Denic; John J Knoedler; Felicity T Enders; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

6.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

7.  Medical comorbidities associated with pediatric kidney stone disease.

Authors:  Anthony J Schaeffer; Zhaoyong Feng; Bruce J Trock; Ranjiv I Mathews; Alicia M Neu; John P Gearhart; Brian R Matlaga
Journal:  Urology       Date:  2010-10-23       Impact factor: 2.649

8.  Relation of urinary calcium and magnesium excretion to blood pressure: The International Study Of Macro- And Micro-nutrients And Blood Pressure and The International Cooperative Study On Salt, Other Factors, And Blood Pressure.

Authors:  Hugo Kesteloot; Ioanna Tzoulaki; Ian J Brown; Queenie Chan; Anisha Wijeyesekera; Hirotsugu Ueshima; Liancheng Zhao; Alan R Dyer; Robert J Unwin; Jeremiah Stamler; Paul Elliott
Journal:  Am J Epidemiol       Date:  2011-05-30       Impact factor: 4.897

9.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 10.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.